Why Izy Healthcare
Izy has deep domain expertise across the Healthcare Space. Together the team has worked on in excess of $10bn transactions ranging from strategic investments/JV to growth capital and M&A.
For more info, contact Joanne Hackett, [email protected]
Deep healthcare specialisation: wide-ranging experience in healthcare with large companies and start-ups in Europe, the US and Asia across life sciences, services, tools and diagnostics and medical devices,
Deep network: Izy has established relationships across the ecosystem from academic through corporate and CVC;
Broad transaction background: project leadership across the full range of M&A and financing, working with Boards, shareholders and outside advisors
Financing experience: led number of public and private equity and debt capital raisings.
Board role: attendance and participation at all Board meetings
Scientific background: especially in genomics, tissue engineering and regenerative medicine. Strong learned technology experience in neural networks, trusted research environments and data driven
Meet The Team
Joanne Hackett PhD
Joanne leads the Healthcare Practice where she works with, incubates and grows the next generation of world leading innovators. Joanne is a clinical academic, entrepreneur, investor and a strategic, creative visionary with global experience spanning successful start-ups to Fortune 500 companies.
David is the Managing Partner of IZY Capital. A Fellow of the Institute of Chartered Accountants, David has spent the last 25 years as a technology analyst, strategist, investment banker and more latterly investor and entrepreneur.
Paolo is a Managing Director at IZY Capital. During a 24-year career in Capital Markets and Investment Banking, much of this time was spent as a Head of Investment Research and as a CEO. With a passion for Angel investing, Paolo has more recently been a mentor and advisor to start-ups and scaling businesses.
Professor Jeremy Hall
Cardiff University: Director of Division of Psychiatry and Clinical Neuroscience, Director of Neuroscience and Mental Health Research Institute, Hon. Consultant Psychiatrist.
Sub Sector: Artificial Intelligence
BIOS is fast becoming a global leader in harnessing the power of AI to decode and encode the signals from brain to body. The Founders, Emil and Oli, have extensive knowledge in computational neuroscience, machine learning and bioengineering. The company has built the world’s largest neural biomarker discovery dataset, uniquely enabling 3rd parties to create neural therapies using their platform.
Sub Sector: Healthtech
IQVIA™ (NYSE:IQV) and Genomics England are collaborating to develop a platform that will connect clinical and de-identified genomics data to accelerate treatment advancements for patients. This alliance will enable faster and more efficient drug research, more robust evidence to support treatment value, and greater access to personalised medicines.
Sub Sector: Healthcare
Circle Health, the independent hospital group, and BMI Healthcare, the UK’s leading independent hospital operator, recently announced that Circle Health has agreed to acquire BMI Healthcare to deliver a new generation of best-in-class hospitals. BMI Healthcare manages a network of hospitals and clinics throughout the UK, with over two million patient visits per year.
Sub Sector: Healthtech
In 2018, as part of a new focus on advancing the treatment of lung cancer, BTG invested $20m in Veran Medical Technologies, Inc. BTG is a global healthcare company focused on Interventional Medicine and Veran is a privately held medical device company whose mission is to empower physicians to diagnose cancer earlier and to enable precision therapy to save lives.